AESTHETIC INJECTABLES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On March 20, 2024, Merz Aesthetics, the world's largest dedicated medical aesthetics company, announced the launch of a new complete educational ecosystem called MAX Merz Aesthetics Exchange. Based on trusted, science-based aesthetics knowledge, it provides an inclusive approach that crosses traditional barriers, ensuring a transformative educational experience customized to the evolving requirements of learners worldwide.
• On February 1, 2024, Merz Aesthetics announced that Radiesse has been approved to treat the décolleté area. Radiesse is a regenerative biostimulator that may regenerate numerous components of skin tissue, resulting in healthier-looking skin. The product is now approved for usage in the décolletage, increasing its versatility.
• In June 2023, Galderma, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Restylane Eyelight for the treatment of undereye hollows, often known as dark shadows, in individuals over 21. Restylane Eyelight, an undereye hyaluronic acid (HA) dermal filler, is the first and only treatment in the U.S. designed with NASHA Technology to address volume loss under the eyes, providing patients with natural-looking results.
• In March 2023, Galderma announced the launch of FACE by Galderma, a unique aesthetic visualization tool powered by augmented reality (AR) that allows aesthetic experts and patients to preview injectable therapy outcomes before treatment begins. This unique method provides patients with a simulated real-time "before and after" view of what is feasible with a tailored treatment plan, perhaps alleviating patient anxieties regarding injectable results.